Modular Automated Sampling Technology (MAST) allows direct aseptic transfer of bioreactor samples to analytical devices, providing rapid and reliable data in bioprocessing.
Capsugel announced that its Modular Automated Sampling Technology (MAST) system is now commercially available. This first-of-its-kind technology directly transfers samples from bioreactors to analytical devices while maintaining process sterility. It allows aseptic collection of accurate, representative samples that generate detailed process information in real-time. MAST was developed by Capsugel to address biopharmaceutical product development and processing challenges.
MAST provides a modular system that is readily scalable and suitable for use throughout the product development process. The system instantaneously provides a wide range of information at the molecular level for media, cells and bioreactor products, allowing for rapid response to maintain optimum bioreactor conditions and maximize yields. Capsugel is also collaborating with several analytical equipment suppliers to integrate process analytical technology (PAT) tools into MAST for bioprocessing.
MAST provides for tailored system design and can be readily expanded with additional sampling modules as required. MASTconnect software allows for configurable, flexible, and user-friendly operation of the MAST system, with special modules for sample scheduling, sample navigation, and analytical data management.
Source: Capsugel
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.